Loading market dashboard
Humana Inc.
HUMHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
On June 04, 2026, Humana Inc (HUM) shares rose 6.8% to a current price of $349.80. The stock has seen significant price performance recently, with a 52-week ran
Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside.
Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
Humana Investigation Continued: Kahn Swick and Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
NEW ORLEANS, May 29, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
ORLANDO, Fla.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, today announced the start of full operations of its newest CenterWell Pharmacy® mail order distribution center, in Orlando, Florida. The $83 million, state-of-the-art facility bolsters capacity for prescription medication delivery across Florida and the country and reinforces Humana's longstanding commitment to providing members and patients across the Sunshine State with a simp.
According to Kiplinger, the Congressional Joint Economic Committee found Medicare Advantage is overpaying insurers by $212 per enrollee.
Deutsche Bank just delivered one of the most aggressive analyst upgrades of 2026 on Humana (NYSE:HUM | HUM Price Prediction), lifting the managed care giant to Buy from Hold while nearly doubling its price target to $441 from $235.
Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation may as well. All of the major indices finished Tuesday lower, and with Q1 earnings all but over and the incoming economic data... Here Are Wednesday's Top Wall Street Analyst Research Calls: BJ's Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More
HUM's Medicare growth, CenterWell expansion and strong cash flow support gains, but rising costs and high leverage keep caution in focus.
Shares of Humana (NYSE:HUM | HUM Price Prediction) are trading near $303 at midday Monday, slightly lower on the session after a flat open.
Humana Inc. is upgraded to Buy as shares rebound from a >65% decline, supported by improved CMS rate decisions and activist investor involvement. Despite 2026 EPS guidance below Q1 levels, HUM targets a sustainable 3%+ Medicare Advantage margin and long-term earnings growth by 2028. Recent Q1 results exceeded revenue and adjusted EPS expectations, with a favorable medical benefit ratio and affirmed 25% MA membership growth for 2026.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Humana Inc. (“Humana” or “the Company”) (NYSE: HUM). On January 18, 2024, the Company announced its financial results for the fourth quarter and full year 2023, disclosing that its benefits expense ratio increased to approximately 91.4% for the fourth quarter of 2023 and approximately.
Humana (NYSE:HUM | HUM Price Prediction) stock received a price target raise to $254 from $182 from Piper Sandler, which maintained a Neutral rating.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana invests more than $1 million to advance health outcomes across Louisiana through grants that support statewide priorities.
We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given our constructive long-term outlook for US natural gas. We exited our position in First Advantage, a leader in the background check space, to pursue other opportunities with less macro exposure and AI-disruption concerns.
We initiated four new positions in Q1, an above-average pace of activity. We also used the increased volatility to upgrade overall portfolio quality. Our three largest new positions were Amazon.com, Universal Music Group and IQVIA Holdings. In addition to sales of Humana and PayPal, we also exited our positions in social technology leader Meta Platforms and beverages company Diageo.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Florida ranks among the top three states in the nation for the largest senior population, with projections showing that one-third of its residents will be over 60 by 2050. However, a new research brief by the Humana Foundation, the philanthropic arm of Humana Inc. for the past 45 years, finds that a significant number of older Floridians are facing mental health challenges, many of which go unrecognized and unaddressed. The research brief, The State of Senior E.
Solid first-quarter results from major insurers like UnitedHealth, Elevance, Cigna and Humana have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. But analysts caution that insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real proving ground.
The April scoreboard is in for managed care. UnitedHealth Group (NYSE:UNH | UNH Price Prediction) stock and Humana (NYSE:HUM) stock both staged ferocious rallies, yet UnitedHealth won by roughly 56 basis points (bps).
HUM posts Q1 earnings beat as premiums surge and membership grows, but rising costs and benefit ratio pressure weigh on profit.
Humana Inc. (HUM) Q1 2026 Earnings Call Transcript
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Humana (HUM) came out with quarterly earnings of $10.31 per share, beating the Zacks Consensus Estimate of $9.97 per share. This compares to earnings of $11.58 per share a year ago.
Humana reported first quarter net income of nearly $1.2 billion as costs of care for older adults in its Medicare Advantage plans eased a bit but remained high.
Filing date: April 29, 2026; see the company's 8-K filing.GAAP diluted EPS was $9.83. This is below the estimated EPS of $10.48.Adjusted diluted EPS was $10.31
Humana reported lower first-quarter profit as the company faces earnings headwinds from lower Medicare Advantage Star Ratings for 2026.
Humana on Wednesday beat Wall Street estimates for first-quarter profit as the health insurer spent less on medical services than expected.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended March 31, 2026 (1Q26) versus the quarter ended March 31, 2025 (1Q25) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 1Q26 (a) 1Q25 (a) Generally Accepted Accounting Principles (GAAP) $1,595 $1,691 Amortization associated with identifiable intangibles 11 15 Pu.
The stock has slumped this year, seesawing on news of how much the government plans to pay insurers that operate Medicare Advantage health plans for seniors.
Shares of UnitedHealth Group (NYSE:UNH | UNH Price Prediction) are up 4% at midday Tuesday, trading near $368, while Humana (NYSE:HUM) stock is also up 4% to $233.
Humana announced on Monday it will launch a pharmacy partnership with Mark Cuban's Cost Plus Drugs, with the health conglomerate's CenterWell pharmacy unit serving as a distributor for the platform.
Mark Cuban's Cost Plus Drug Company and Humana's CenterWell Pharmacy Monday confirmed they have formed a partnership “to develop new end-to-end employer prescription solutions.”
LOUISVILLE, Ky. & DALLAS--(BUSINESS WIRE)--CenterWell Pharmacy®, a leader in specialty pharmacy and home delivery pharmacy and part of Humana Inc. (NYSE:HUM), today announced a deepened partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to develop new, end-to-end employer prescription solutions. As part of this collaboration, Cost Plus Drugs has selected CenterWell Pharmacy® as a pharmacy partner. In addition, Cost Plus Drugs' digital pharmacy SaaS solution, SwiftyRx™, will be.
Cwm LLC lowered its stake in Humana Inc. (NYSE: HUM) by 56.1% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,172 shares of the insurance provider's stock after selling 9,178 shares during the period. Cwm LLC's holdings in Humana
HUM heads into Q1 earnings with strong revenue growth expectations, but rising operating costs and a higher benefits ratio may weigh on profits.
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
On April 21, 2026, Humana Inc (HUM) shares rose 3.3% today, closing at $217.36. The stock has seen significant movement over the past month, gaining 28.6%, alth
We purchased a new holding in the consumer discretionary sector. We also eliminated several holdings, using the proceeds to fund investments we believe have better risk/reward profiles. Chevron shares rose due to higher oil prices, as the overall energy sector benefited from tight global energy supplies amid heightened geopolitical risk. A softer outlook for net interest income appeared to weigh on Wells Fargo hares as changing interest rate expectations created headwinds across the banking sector.
PHILADELPHIA, April 21, 2026 (GLOBE NEWSWIRE) -- Kaskela Law is investigating potential breach of fiduciary duty claims concerning Humana Inc. (NYSE: HUM) (“Humana”) on behalf of the company's long-term shareholders. Click here for additional information about your shareholder legal rights: https://kaskelalaw.com/case/humana/ Recently a federal securities fraud complaint was filed against Humana on behalf of certain investors who purchased shares of the company's stock between July 27, 2022 and October 1, 2024 (the “Wrongdoing Period”).
LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Introduces the Fulfillment Index, a New Measure of What It Means to Age Well.
LOUISVILLE, Ky., April 19, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the Humana, Inc. data breach.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026. About Humana Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – de.
LOUISVILLE, Ky.--(BUSINESS WIRE)--A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program helped Medicare Advantage beneficiaries with COPD use their inhalers more effectively. Researchers from Humana Healthcare Research and University of Chicago Medicine (UChicago Medicine) found that Humana members with COPD and low medication adherence who participated in the program in 2020 significantl.
Program launching June 1, 2026 will expand access to community-based palliative care for members living with serious illness HOUSTON, April 14, 2026 /PRNewswire/ -- Tuesday Health today announced a new partnership with Humana Inc. (NYSE: HUM) to expand access to value-based palliative care for Texans living with serious illness, marking another step in the company's growing national footprint. Launching June 1, the program will support eligible Humana members and their caregivers with coordinated clinical guidance, proactive symptom management and ongoing support designed to improve quality of life and help members receive care aligned with their individual goals.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Robert S. Field has been elected as a member of the Company's Board of Directors, effective immediately following the Company's 2026 Annual Meeting of Stockholders. Field is the Principal and Managing Member of ηMed Capital Management LLC, an investment firm focused on U.S. healthcare services companies, primarily in the managed care industry. He previously served as a senior analyst at Luxor Capital, a multi-strateg.
HUM taps pharmacists via a value-based program in Ohio to boost hypertension and diabetes outcomes while aiming to curb costs and improve care access.
LOUISVILLE, Ky. & BALTIMORE--(BUSINESS WIRE)--Humana goes live with b.well to deliver on health data interoperability goals.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Healthy Horizons in Ohio and CPESN USA launch value-based Pharmacist Quality Rewards program to improve chronic condition care.
Humana (HUM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
A much larger-than-expected increase in Medicare Advantage payment rates triggered a broad relief rally across health insurer stocks on Monday, with UnitedHealth and Humana leading the way.
UnitedHealth Group (NYSE:UNH) stock is up nearly 11% today, moving from $281.36 to $311 and change, as the managed care sector stages a powerful relief rally.
4:20pm: Middle East tensions keep investors on alert US stocks finished modestly mixed on Tuesday as investors weighed geopolitical developments in the...
The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly 1% street expectation.
Shares of US health insurers surged on Tuesday morning after the Trump administration announced that Medicare Advantage payments will increase more than initially projected. The Centers for Medicare & Medicaid Services (CMS), which oversees government-funded health programs including Medicare, said it will raise payments to private Medicare insurers by a net average of 2.48% in 2027.
On Monday, the Centers for Medicare & Medicaid Services (CMS) released 2027 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies.
